WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke Auregen BioTherapeutics wurde als Wortmarke am 13.04.2017 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Wortmarke |
| Aktenzeichen | 1361577 |
| Registernummer | 694989 |
| Länder | 
|
| Basismarke |
Nr. 694989,
14. Oktober 2016
|
| Anmeldedatum | 13. April 2017 |
| Ablaufdatum | 13. April 2027 |
Markeninhaber
Avenue Giuseppe-Motta 31-37
1202 Genève
CH
1202 Genève
CH
Markenvertreter
Rue Saint-Honoré 1,
Case postale 2510
CH
Waren und Dienstleistungen
01
Hydrogel-based polymer coatings; lactic acid polymers;
linear aqueous polymer gels; photocurable compositions
containing polymers; chemical products for polymerization;
cell culture media for the biotechnology industry; tissue
and matrices of synthesized biological tissue, namely
tissue, organ, connective, epithelial, muscle, nerve tissue
and matrices from humans and animals for medical and
scientific research; biologically compatible materials,
namely hydrogels used to create polymer networks for the
manufacture of living tissue
05
Pharmaceutical preparations of regenerative tissue;
biological implants; biological tissue for implantation;
cells for medical use; human tissue for allografts; living
cells for medical use; implants for guided tissue
regeneration; implants comprising living tissue;
implantable materials for use in guided tissue regeneration;
skin grafts; surgical implants composed of living tissue;
grafts [living tissues]; artificial biological tissue and
organs for medical use; biological molecules to assist with
the development of tissue; natural biomaterials for bone
and tissue augmentation for medical use; pharmaceutical
products for tissue regeneration, tissue repair, tissue
treatment; pharmaceutical preparations for the treatment of
bone diseases, cartilage diseases, degeneration of tendons
and ligaments; biomaterials for bone filling; biomaterials
for filling cartilage; surgical implants (living tissues);
biological tissue cultures for medical purposes
07
Three-dimensional [3D] printers; Three-dimensional [3D]
bioprinters; computer-powered machines, and the components
thereof, for the manufacture of three-dimensional parts;
machines for the manufacture of three-dimensional (3D)
living tissue; machines, namely three-dimensional
bioprinters (3D) for printing living tissue; cartridges with
printing materials, cartridges with biological printing
materials, printing cartridges with biomaterials for
three-dimensional printing
09
Laboratory apparatus for the manufacture of living tissue
and three-dimensional organs; bioreactors for cell culture;
print heads for ink-jet printers; laboratory equipment for
scientific use and research, namely systems comprising a
liquid distributor, an imaging facility, control software,
analysis software
10
Surgical, medical and dental apparatus and instruments; bone
substitutes for surgical use; injectors for medical use;
synthetic biomaterials for the substitution of tissue, for
the recovery, maintenance and/or the repair of the function
of diseased or damaged human or animal tissue (tissue
engineering); synthetic implants and transplants and
modified implants and transplants, tissue, cells and/or
molecules for replacing and/or assisting with the function
of missing or damaged body parts; synthetic hard and soft
tissue, in particular synthetic bone for transplantation and
diagnostics, synthetic biomaterials for bone substitution;
modified implants and transplants in endogenous material,
tissue, cells and/or molecules, for replacing and/or
assisting with the function of missing or damaged body
parts
40
3D printing services; customized creation of
three-dimensional parts using rapid prototyping equipment;
3D biological printing services; biological printing
services
42
Scientific research and development; biomimetics research;
technical research in the fields of biomimetics, biology,
medical devices, materials science, biomaterials, 3D
bioprinting and tissue engineering; research and
development of medical devices; three-dimensional
biological printing research; tissue engineering research;
scientific and medical research and development in the field
of bioprinting; research and development of 3D processes
and technology; scientific research consultancy in the
fields of three-dimensional printing; scientific services
relating to the isolation and culture of human tissue and
cells; scientific and medical research and development in
the field of the manufacture of tissue; development and
culture of artificial tissue and cells (tissue engineering);
tissue engineering services; industrial analysis and
research services in the field of tissue engineering,
research in the fields of regenerative biotherapies;
research and testing services in the field of regenerative
biotherapies
44
Medical services, namely in the field of cellular
immunotherapies and transplantation; medical treatment
services; human cell and tissue banking services; medical
services for the collection and preservation of cells for
medical use
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 29. April 2019 | 2019/22 Gaz | IL | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 06. November 2018 | 2018/45 Gaz | US | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 29. Oktober 2018 | 2019/4 Gaz | IN | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 16. Oktober 2018 | 2018/43 Gaz | RU | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 16. August 2018 | 2018/35 Gaz | JP | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 02. Juli 2018 | 2018/29 Gaz | CN | Ablehnung |
| 24. Mai 2018 | 2018/22 Gaz | IL | Ablehnung |
| 27. März 2018 | 2018/16 Gaz | RU | Ablehnung |
| 22. März 2018 | 2018/22 Gaz | CH | RAW: Partial Ceasing Effect |
| 08. März 2018 | 2018/10 Gaz | JP | Ablehnung |
| 26. Januar 2018 | 2018/8 Gaz | EM | Ablehnung |
| 23. November 2017 | 2018/7 Gaz | EM | RAW: No Effect Limitation |
| 07. November 2017 | 2017/49 Gaz | CH | RAW: Partial Ceasing Effect |
| 16. September 2017 | 2017/38 Gaz | US | Ablehnung |
| 11. September 2017 | 2017/38 Gaz | IN | Ablehnung |
| 28. August 2017 | RAW: Limitation | ||
| 13. April 2017 | 2017/32 Gaz | CH | Eintragung |
ID: 141361577